Hemicrania continua: Indomethacin induced myoclonus
Myoclonus has been described rarely as an adverse effect with some non-steroidal anti-inflammatory drugs, but never with indomethacin. Indomethacin is a common nonsteroidal anti-inflammatory drug used for various primary headache disorders, including hemicrania continua. We present a rare case of a...
Saved in:
Published in | Clinical neurology and neurosurgery Vol. 206; p. 106703 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.07.2021
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Myoclonus has been described rarely as an adverse effect with some non-steroidal anti-inflammatory drugs, but never with indomethacin. Indomethacin is a common nonsteroidal anti-inflammatory drug used for various primary headache disorders, including hemicrania continua. We present a rare case of a 45-year-old male with hemicrania continua who developed myoclonus from indomethacin. These movements resolved completely following discontinuation of indomethacin. The disturbance on the serotonergic and GABAergic systems may be associated with indomethacin induced myoclonus. Clinicians and patients should be mindful with this potential side effect with indomethacin.
•Indomethacin is a common non-steroidal anti-inflammatory drug used for various primary headache disorders.•Drug-induced myoclonus has never been described with the use of indomethacin.•The serotonergic and GABAergic systems are involved in the pathophysiology of myoclonus.•Increased serotonergic transmission may be involved in the induction of myoclonus.•Indomethacin can inhibit GABA reuptake. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Case Study-2 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
ISSN: | 0303-8467 1872-6968 1872-6968 |
DOI: | 10.1016/j.clineuro.2021.106703 |